More from Investing
These recently downgraded names are displaying both quantitative and technical deterioration.
Here's how I'd play the SPDR S&P Biotech exchange-traded fund.
Trading in multiple time frames not only reduces risks, but also provides strategic flexibility. Let me show you what I mean and how to do it.
This name has been down, but now I think it's charged up to cruise into the year's end.